Daxilume Trademark Details

This mark is alive with a status of First Extension - Granted. The last case file activity for this mark occured 7 years ago on Wednesday, August 17, 2016, according to the United State Patent & Trademark Office
Word Mark Daxilume
Status Alive 730 — First Extension - Granted
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 86648882
Status Date Wednesday, August 17, 2016
Filing Date Wednesday, August 17, 2016
Attorney Richard Friedman

Correspondent

RICHARD FRIEDMAN
Pfizer Inc
235 E 42nd St
New York, NY 10017-5703

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in Mark The wording "DAXILUME" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, June 8, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.